Category

Family Office Networks Webinar Series
Novel scientific insights to unlock the full potential of B cell therapeutics Range of treatment opportunities for cancer immunotherapy and B cell-driven rare diseases Lead program, AT-1965, advancing toward IND and initiation of solid tumor clinical study in 2H2020 Positive pre-IND interaction with FDA; alignment on 2020 IND submission and clinical initiation for AT-1965 Collaborative...
Read More
Why Choice Housing Investments? The most recent completed quarter, gross annualized Cash on Cash returns were at 12.5% and the Preferred Return was delivered to all investors We continue to see opportunities for investment, yet are stable enough to be selective and not chase deals that have marginal returns Despite the current crisis, multifamily real...
Read More
BACKGROUND ON COMPANY EPS is a privately held, technology driven company that is focused on developing new power solutions through the manufacturing of highly efficient, re-engineered, small sized turbine engines. Two separate models of these turbines will generate PRIMARY POWER (not just back-up power) for use in the residential, commercial, industrial, and retail sectors. One turbine...
Read More
BACKGROUND ON COMPANY EPS is a privately held, technology driven company that is focused on developing new power solutions through the manufacturing of highly efficient, re-engineered, small sized turbine engines. Two separate models of these turbines will generate PRIMARY POWER (not just back-up power) for use in the residential, commercial, industrial, and retail sectors. One turbine...
Read More
Background on Company The aerospace market is being disrupted by electrification, creating opportunities for new types of aircraft, improved economics, and lower emissions. Erik Lindbergh and a team of experienced technology and business leaders founded VerdeGo Aero to enable the next generation of clean, quiet, flight. VerdeGo Aero’s electric powertrains deliver significant competitive advantages for...
Read More
BACKGROUND ON COMPANY Revolutionary cell therapy targeting a cure for both Type 1 and Type 2 diabetes Successful demonstration of curative properties in animal models, with a human clinical trial targeted for 2021 Utilization of ethically derived human induced pluripotent stem cells (iPSC, non-embryonic), which have the potential for significant scaleup to reach greater patient...
Read More
Chris Brawner has been involved in over $650M in farmland investments over the past decade. Discover the benefits of investing in farmland during this webinar. By 2030 the global population is expected to be +8 Billion. The developing world's middle class continues to update its diet which includes more protein, which will take more grains...
Read More
Chromatix is an early stage company with proven patent portfolio of unique color changing chemistry that allows “color on demand” to provide a platform for multiple uses across diverse industries. On demand color aesthetics for global brands On demand light control for visual acuity Established sales portfolio with multiple diverse use cases Currently raising $10MM...
Read More
Lactocore is a preclinical stage company at the cutting edge of computer-aided drug discovery. There is a tremendous unmet need for new drugs with novel mechanisms of action and drastically improved safety profiles in the areas of depression and anxiety. Lactocore is focused on fast and efficient early stage development to generate high quality candidates...
Read More
Nuzuna Zone Fitness provides a revolutionary new power-driven training solution and functional workout system with a wireless EMS system built into a tracksuit. As a worldwide unique EMS functional workout system, it delivers the full potential for intense full-body muscle training with complete freedom of movement. The Nuzuna brand spans both deep and wide with...
Read More
1 2 3 4